Brokerages Set HealthEquity, Inc. (NASDAQ:HQY) Target Price at $110.71

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the fourteen research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $110.71.

A number of research firms have weighed in on HQY. BTIG Research upped their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Mizuho started coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target for the company. Barrington Research boosted their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research note on Monday, December 2nd. Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a report on Tuesday, December 10th. Finally, JMP Securities lifted their price target on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th.

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares of the company's stock, valued at $4,540,582.62. The trade was a 13.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Frank Corvino sold 1,039 shares of the company's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,539 shares of company stock valued at $4,040,303 in the last quarter. Insiders own 2.20% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in HQY. Holocene Advisors LP purchased a new position in shares of HealthEquity in the 3rd quarter valued at about $1,246,000. GSA Capital Partners LLP purchased a new stake in HealthEquity in the third quarter valued at $638,000. Natixis Advisors LLC boosted its stake in HealthEquity by 29.8% in the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock valued at $17,122,000 after acquiring an additional 48,009 shares in the last quarter. Vaughan Nelson Investment Management L.P. grew its holdings in shares of HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock worth $69,034,000 after purchasing an additional 226,563 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. increased its position in shares of HealthEquity by 29.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company's stock worth $5,535,000 after purchasing an additional 14,573 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

Shares of HQY stock traded up $0.66 during trading hours on Friday, hitting $97.47. 455,451 shares of the company's stock were exchanged, compared to its average volume of 461,626. HealthEquity has a fifty-two week low of $65.01 and a fifty-two week high of $105.82. The firm has a market cap of $8.45 billion, a P/E ratio of 89.42, a P/E/G ratio of 1.08 and a beta of 0.54. The company has a quick ratio of 4.10, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a 50 day moving average of $96.88 and a two-hundred day moving average of $85.48.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.